A remarkable adaptive paradigm of heart performance and protection emerges in response to marked cardiac-specific overexpression of ADCY8
Open Access
- 14 December 2022
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Abstract
Adult (3 month) mice with cardiac-specific overexpression of adenylyl cyclase (AC) type VIII (TGAC8) adapt to an increased cAMP-induced cardiac workload (~30% increases in heart rate, ejection fraction and cardiac output) for up to a year without signs of heart failure or excessive mortality. Here, we show classical cardiac hypertrophy markers were absent in TGAC8, and that total left ventricular (LV) mass was not increased: a reduced LV cavity volume in TGAC8 was encased by thicker LV walls harboring an increased number of small cardiac myocytes, and a network of small interstitial proliferative non-cardiac myocytes compared to wild type (WT) littermates; Protein synthesis, proteosome activity, and autophagy were enhanced in TGAC8 vs WT, and Nrf-2, Hsp90α, and ACC2 protein levels were increased. Despite increased energy demands in vivo LV ATP and phosphocreatine levels in TGAC8 did not differ from WT. Unbiased omics analyses identified more than 2,000 transcripts and proteins, comprising a broad array of biological processes across multiple cellular compartments, which differed by genotype; compared to WT, in TGAC8 there was a shift from fatty acid oxidation to aerobic glycolysis in the context of increased utilization of the pentose phosphate shunt and nucleotide synthesis. Thus, marked overexpression of AC8 engages complex, coordinate adaptation "circuity" that has evolved in mammalian cells to defend against stress that threatens health or life (elements of which have already been shown to be central to cardiac ischemic pre-conditioning and exercise endurance cardiac conditioning) that may be of biological significance to allow for proper healing in disease states such as infarction or failure of the heart.Keywords
All Related Versions
Funding Information
- National Heart, Lung, and Blood Institute (1R01HL155218)
- National Heart, Lung, and Blood Institute (R01 HL136918)
- National Heart, Lung, and Blood Institute (R01 HL1155760)
- National Heart, Lung, and Blood Institute (HL63030)
- National Heart, Lung, and Blood Institute (HL61912)
- American Heart Association (#18CDA34110140)
- American Heart Association (#20TPA35500008)
This publication has 95 references indexed in Scilit:
- Heme Oxygenase-1 Prevents Cardiac Dysfunction in Streptozotocin-Diabetic Mice by Reducing Inflammation, Oxidative Stress, Apoptosis and Enhancing AutophagyPLOS ONE, 2013
- RGS2 overexpression or Gi inhibition rescues the impaired PKA signaling and slow AP firing of cultured adult rabbit pacemaker cellsJournal of Molecular and Cellular Cardiology, 2012
- Creatine kinase–mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starvedJournal of Clinical Investigation, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking TalePhysiological Reviews, 2010
- Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing HeartThe Annals of Thoracic Surgery, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Calcium–calcineurin signaling in the regulation of cardiac hypertrophyBiochemical and Biophysical Research Communications, 2004
- The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C TerminusJournal of Biological Chemistry, 2001
- The Hallmarks of CancerCell, 2000